ELECT 24 Top Ad

Analyst Update: UnitedHealth, Discover, and Kite Pharma

Analysts revised their ratings and price targets on UnitedHealth Group Inc (NYSE:UNH), Discover Financial Services (NYSE:DFS), and Kite Pharma Inc (NASDAQ:KITE)

Apr 20, 2016 at 3:24 PM
facebook X logo linkedin


Analysts are weighing in on healthcare concern UnitedHealth Group Inc (NYSE:UNH), financial interest Discover Financial Services (NYSE:DFS), and biotech stock Kite Pharma Inc (NASDAQ:KITE). Here's a quick roundup of today's brokerage notes on UNH, DFS, and KITE.

  • UNH is up 3.4% at $134.88, after hitting a new record high of $134.98 earlier, bringing its year-to-date lead to nearly 15%. No fewer than nine brokerage firms have raised their price targets on the stock since the company reported strong first-quarter earnings on Tuesday morning, and announced that it would exit Affordable Care Act (ACA) exchanges in most states by 2017. Mizuho Securities set the loftiest target at $156 -- a roughly 16% premium over the stock's current value. Bearish option traders may be kicking rocks as UnitedHealth Group treks farther north, but analysts have largely been in the equity's corner, with 15 out of 17 rating UNH a "buy" or better
  • After reporting better-than-expected earnings last night, DFS earned price-target hikes from at least seven analysts -- the highest target set at $75 by Oppenheimer -- while Susquehanna broke the trend, lowering its target on Discover Financial Services to $66. The stock has added 8% at $56.73, continuing a strong uptrend that began after the shares hit a nearly three-year low of $42.86 in mid-February. DFS has since been enjoying solid support from its rising 20-day moving average. Options traders have been relatively optimistic of late, buying to open 3.52 DFS calls for each put on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) over the past two weeks. And short sellers have been backing off, as well, with these bearish bets falling nearly 24% during the most recent two-week reporting period.
  • KITE is 6% higher at $48.91, after the drugmaker reported upbeat results from a Phase 1 trial of its investigational non-Hodgkin's lymphoma treatment. Kite Pharma Inc is shaking off a price-target cut to $72 from $75 at Jefferies, but the shares are still off nearly 21% year-to-date. In fact, KITE gave up 57% between its record high of $89.84 in November, and its annual low of $38.41, less than three months later. The shares have also been stuck beneath their 100-day moving average since mid-December. Meanwhile, short interest on KITE remains elevated, representing 13.6% of the equity's available float. At KITE's typical daily trading pace, it would take more than a week to buy back these bearish positions.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Yahoo! Inc., Intuitive Surgical, Inc., and VMware, Inc. and Analyst Downgrades: Apple Inc., CalAmp Corp., and Intel Corporation.
 

Biden’s government just announced a new government "stimulus program"...

And it could hand you a payment for as much as $7,882 — each quarter.

See, it has to do with a recent 19-page memo from Biden’s office...

Directing the government to once again send a form of "stimulus payments" to the mailboxes of Americans during these difficult times.

Better still, you can collect these payouts every single quarter — for life...

Payments run as high as $7,882... And it only takes five minutes to sign up.

I call this the "Stimulus Stipends" program…

And Forbes recently declared that you can "retire rich" thanks to this program.

So if you want to start cashing in your quarterly payouts — courtesy of the U.S government...

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here. 
 (ad)
 

election 2024 report

                                                  AD                                                  
best AI trade you can make today…?
(it’s not MSFT, GOOGL, AMZN or AAPL)

                                                  AD                                                  

 
 

VOLATILITY SCORECARD

 


                                               AD                                                    
Crazy Opportunity!! Tiny AI Stock just $3
“This Type of AI Will Be Worth “Ten MSFTs.”

                                               AD                                                    

 
4 AI STOCKS TO BUY NOW
 

                                                  AD                                                  
best AI trade you can make today…?
(it’s not MSFT, GOOGL, AMZN or AAPL)

                                                  AD